Eli Lilly’s New Lineup: India Gets the Full Arsenal of Mounjaro KwikPens

Unknown Apr 02, 2026 850 Views

Eli Lilly obtained Indian regulatory approval for its KwikPen formulation of Mounjaro (tirzepatide), a once-weekly injectable treatment used to treat type 2 diabetes and obesity. The pen is now available in all approved dose strengths—2.5 mg through 15 mg, giving patients a more convenient...